Articles

Treasury yields steady ahead of U.S. GDP data that sets stage for inflation report

Treasury yields were steady Thursday ahead of pivotal data on the U.S. economy.

A bucket list of cities to visit for literature lovers, from Emily Dickinson to Jack Kerouac

Literature buffs can get to know their favorite writers and walk in their footsteps just by visiting these authors’ homes and haunts.

The 2024 Kia EV9 and the Rivian R1S compared: Which of these 3-row electric SUVs is better?

These two midsize SUVs carry up to seven passengers and offer plenty of range, but they are designed to do different things.

STMicroelectronics slashes guidance over slump in automotive industry

The Swiss chipmaker reported an 18.4% drop in its first-quarter sales as it cut its guidance for the year.

Adyen shares slump as payments processor meets revenue estimates

Shares of Adyen slumped Thursday as the payments processor met revenue expectations even after processing more volume than anticipated.

Anglo American shares surge on possible BHP offer

Anglo American shares surged Thursday after mining giant BHP approached it about making a takeover bid.

Mining giant BHP offers to buy rival Anglo American in potential megadeal

Mining giant BHP has offered to buy Anglo American, a long-time rival with a market capitalization of about $35 billion, in a potential megadeal that could reshape the global mining industry.

Rubrik prices its IPO at $32, above expected range

Rubrik Inc. priced its initial public offering late Wednesday at $32 a share.

Zuckerberg burns some goodwill on Wall Street as he plows forward with the metaverse

Investors clearly also concerned that Meta’s spending will include a lot more on virtual and augmented reality.

A new wave of e-commerce disruption could close 45,000 retail stores over the next five years, analysts say

UBS analysts have suggested that e-commerce isn’t done upending brick-and-mortar retail just yet.

Cidara Therapeutics shares surge 30% after reacquiring flu treatment

Shares of Cidara Therapeutics rose sharply after the company announced a reshuffling of its portfolio of drug candidates.

Acrivon Therapeutics’ shares climb 14% on plans to present cancer-test data

Shares of Acrivon Therapeutics advanced in post-market trading after the biopharmaceutical company said it would present clinical trial data in connection with a biomarker test for ovarian and endometrial cancers.
1 1,369 1,370 1,371 1,372 1,373 2,451